Advertisement

Reoperative Surgical Planning and Adjunct Localization Studies

  • Jonathon O. Russell
  • Salem I. Noureldine
  • Nafi Aygun
  • Ralph P. TufanoEmail author
Chapter

Abstract

Pathology of the parathyroid glands is fairly prevalent in the United States. Each year, approximately ten cases of primary hyperparathyroidism (HPT) per 100,000 people are diagnosed in those younger than 40 years. The incidence is estimated to be four times higher in patients older than 60 years of age [1]. Surgery for primary HPT, performed by an experienced surgeon, is curative in more than 95% of cases [2]. In contrast, the success rate for low-volume surgeons is only 70% [3]. Consequently, the hyperparathyroid state may not be cured for a number of patients following surgery. Those not cured either remain hypercalcemic in the immediate postoperative period or redevelop hypercalcemia after a period of normocalcemia. Hypercalcemia persisting or recurring within 6 months after initial parathyroidectomy is referred to as persistent HPT. Hypercalcemia recurring more than 6 months after an apparently curative initial parathyroidectomy is referred to as recurrent HPT. Regardless of terminology, in both cases, the patient is at continued risk of metabolic complications from hypercalcemia and may continue to have discomfort from the associated symptoms. Despite advances in preoperative imaging and adjunctive intraoperative tools, the incidence of persistent or recurrent HPT has been reported to be as high as 30% [4–6].

Keywords

Parathyroid glands Thymus Pharyngeal pouches Recurrent laryngeal nerve Thyroid gland 

References

  1. 1.
    Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med. 1980;302(4):189–93.CrossRefPubMedGoogle Scholar
  2. 2.
    Clark OH. Symposium: parathyroid disease—part 1. Contemp Surg. 1998;52:137–52.Google Scholar
  3. 3.
    Malmaeus J, Granberg PO, Halvorsen J, Akerstrom G, Johansson H. Parathyroid surgery in Scandinavia. Acta Chir Scand. 1988;154(7–8):409–13.PubMedGoogle Scholar
  4. 4.
    Wadstrom C, Zedenius J, Guinea A, Reeve TS, Delbridge L. Re-operative surgery for recurrent or persistent primary hyperparathyroidism. Aust N Z J Surg. 1998;68(2):103–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Mundschenk J, Klose S, Lorenz K, Dralle H, Lehnert H. Diagnostic strategies and surgical procedures in persistent or recurrent primary hyperparathyroidism. Exp Clin Endocrinol Diabetes. 1999;107(6):331–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Al-Fehaily M, Clark OH. Persistent or recurrent primary hyperparathyroidism. Ann Ital Chir. 2003;74(4):423–34.PubMedGoogle Scholar
  7. 7.
    Caron NR, Sturgeon C, Clark OH. Persistent and recurrent hyperparathyroidism. Curr Treat Options in Oncol. 2004;5(4):335–45.CrossRefGoogle Scholar
  8. 8.
    Clark OH, Way LW, Hunt TK. Recurrent hyperparathyroidism. Ann Surg. 1976;184(4):391–402.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Marx SJ, Stock JL, Attie MF, Downs RW Jr, Gardner DG, Brown EM, et al. Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med. 1980;92(3):351–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Brown RC, Aston JP, Weeks I, Woodhead JS. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab. 1987;65(3):407–14.CrossRefPubMedGoogle Scholar
  11. 11.
    Bouillon R, Coopmans W, Degroote DE, Radoux D, Eliard PH. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem. 1990;36(2):271–6.PubMedGoogle Scholar
  12. 12.
    Wells SA Jr, Debenedetti MK, Doherty GM. Recurrent or persistent hyperparathyroidism. J Bone Miner Res. 2002;17(Suppl 2):N158–62.PubMedGoogle Scholar
  13. 13.
    Mariette C, Pellissier L, Combemale F, Quievreux JL, Carnaille B, Proye C. Reoperation for persistent or recurrent primary hyperparathyroidism. Langenbeck's Arch Surg. 1998;383(2):174–9.CrossRefGoogle Scholar
  14. 14.
    Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138(4):583–7. discussion 7–90CrossRefPubMedGoogle Scholar
  15. 15.
    Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL III. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003;134(6):973–9. discussion 9–81CrossRefPubMedGoogle Scholar
  16. 16.
    Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg. 2006;141(5):483–7. discussion 7–8CrossRefPubMedGoogle Scholar
  17. 17.
    Irvin GL III, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg. 2004;28(12):1287–92.CrossRefPubMedGoogle Scholar
  18. 18.
    Kutler DI, Moquete R, Kazam E, Kuhel WI. Parathyroid localization with modified 4D-computed tomography and ultrasonography for patients with primary hyperparathyroidism. Laryngoscope. 2011;121(6):1219–24.CrossRefPubMedGoogle Scholar
  19. 19.
    McIntyre CJ, Allen JL, Constantinides VA, Jackson JE, Tolley NS, Palazzo FF. Patterns of disease in patients at a tertiary referral centre requiring reoperative parathyroidectomy. Ann R Coll Surg Engl. 2015;97(8):598–602.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Parikh PP, Farra JC, Allan BJ, Lew JI. Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism. Am J Surg. 2015;210(1):117–22.CrossRefPubMedGoogle Scholar
  21. 21.
    Ginsburg M, Christoforidis GA, Zivin SP, Obara P, Wroblewski K, Angelos P, et al. Adenoma localization for recurrent or persistent primary hyperparathyroidism using dynamic four-dimensional CT and venous sampling. J Vasc Interv Radiol. 2015;26(1):79–86.CrossRefPubMedGoogle Scholar
  22. 22.
    Cham S, Sepahdari AR, Hall KE, Yeh MW, Harari A. Dynamic parathyroid computed tomography (4DCT) facilitates reoperative parathyroidectomy and enables cure of missed hyperplasia. Ann Surg Oncol. 2015;22(11):3537–42.CrossRefPubMedGoogle Scholar
  23. 23.
    Noureldine SI, Aygun N, Walden MJ, Hassoon A, Gujar SK, Tufano RP. Multiphase computed tomography for localization of parathyroid disease in patients with primary hyperparathyroidism: how many phases do we really need? Surgery. 2014;156(6):1300–6. discussion 13006–7CrossRefPubMedGoogle Scholar
  24. 24.
    Kluijfhout WP, Venkatesh S, Beninato T, Vriens MR, Duh QY, Wilson DM, et al. Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism. Surgery. 2016;160(3):747–54.CrossRefPubMedGoogle Scholar
  25. 25.
    Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48(7):1084–9.CrossRefPubMedGoogle Scholar
  26. 26.
    MacFarlane MP, Fraker DL, Shawker TH, Norton JA, Doppman JL, Chang RA, et al. Use of preoperative fine-needle aspiration in patients undergoing reoperation for primary hyperparathyroidism. Surgery. 1994;116(6):959–64. discussion 64–5PubMedGoogle Scholar
  27. 27.
    Stephen AE, Milas M, Garner CN, Wagner KE, Siperstein AE. Use of surgeon-performed office ultrasound and parathyroid fine needle aspiration for complex parathyroid localization. Surgery. 2005;138(6):1143–50. discussion 50–1CrossRefPubMedGoogle Scholar
  28. 28.
    Sachs BA, Pollatta J. Angiographic ablation of parathyroid adenomas. In: Kadir S, editor. Current practice of interventional radiology. Philadelphia, PA: BC Decker; 1991.Google Scholar
  29. 29.
    Miller DL, Chang R, Doppman JL, Norton JA. Localization of parathyroid adenomas: superselective arterial DSA versus superselective conventional angiography. Radiology. 1989;170(3 Pt 2):1003–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Sugg SL, Fraker DL, Alexander R, Doppman JL, Miller DL, Chang R, et al. Prospective evaluation of selective venous sampling for parathyroid hormone concentration in patients undergoing reoperations for primary hyperparathyroidism. Surgery. 1993;114(6):1004–9. discussion 9–10PubMedGoogle Scholar
  31. 31.
    Jones JJ, Brunaud L, Dowd CF, Duh QY, Morita E, Clark OH. Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism. Surgery. 2002;132(6):944–50. discussion 50–1CrossRefPubMedGoogle Scholar
  32. 32.
    Lebastchi AH, Aruny JE, Donovan PI, Quinn CE, Callender GG, Carling T, et al. Real-time super selective venous sampling in remedial parathyroid surgery. J Am Coll Surg. 2015;220(6):994–1000.CrossRefPubMedGoogle Scholar
  33. 33.
    Pollack G, Pollack A, Delfiner J, Fernandez J. Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Laryngoscope. 2009;119(10):1941–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Kuriloff DB, Sanborn KV. Rapid intraoperative localization of parathyroid glands utilizing methylene blue infusion. Otolaryngol Head Neck Surg. 2004;131(5):616–22.CrossRefPubMedGoogle Scholar
  35. 35.
    Han N, Bumpous JM, Goldstein RE, Fleming MM, Flynn MB. Intra-operative parathyroid identification using methylene blue in parathyroid surgery. Am Surg. 2007;73(8):820–3.PubMedGoogle Scholar
  36. 36.
    Ahmed TS. Methylene blue toxicity following infusion to localize parathyroid adenoma. J Laryngol Otol. 2006;120:708. author reply -9CrossRefPubMedGoogle Scholar
  37. 37.
    Vutskits L, Briner A, Klauser P, Gascon E, Dayer AG, Kiss JZ, et al. Adverse effects of methylene blue on the central nervous system. Anesthesiology. 2008;108(4):684–92.CrossRefPubMedGoogle Scholar
  38. 38.
    Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126(6):1023–8. discussion 8–9CrossRefPubMedGoogle Scholar
  39. 39.
    Rubello D, Casara D, Giannini S, Piotto A, De Carlo E, Muzzio PC, et al. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results. Q J Nucl Med. 2003;47(2):129–38.PubMedGoogle Scholar
  40. 40.
    Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL. Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg. 2002;137(6):659–68. discussion 68–9CrossRefPubMedGoogle Scholar
  41. 41.
    Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg. 2003;238(3):332–7. discussion 7–8PubMedPubMedCentralGoogle Scholar
  42. 42.
    Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y, et al. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg. 2004;139(11):1175–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Chen H, Mack E, Starling JR. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg. 2005;242(3):375–80. discussion 80–3PubMedPubMedCentralGoogle Scholar
  44. 44.
    Inabnet WB III, Kim CK, Haber RS, Lopchinsky RA. Radioguidance is not necessary during parathyroidectomy. Arch Surg. 2002;137(8):967–70.CrossRefPubMedGoogle Scholar
  45. 45.
    Westra WH, Pritchett DD, Udelsman R. Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section. Am J Surg Pathol. 1998;22(5):538–44.CrossRefPubMedGoogle Scholar
  46. 46.
    Hosking SW, Jones H, du Boulay CE, McGinn FP. Surgery for parathyroid adenoma and hyperplasia: relationship of histology to outcome. Head Neck. 1993;15(1):24–8.CrossRefPubMedGoogle Scholar
  47. 47.
    Clerici T, Brandle M, Lange J, Doherty GM, Gauger PG. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease. World J Surg. 2004;28(2):187–92.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Jonathon O. Russell
    • 1
  • Salem I. Noureldine
    • 1
  • Nafi Aygun
    • 2
  • Ralph P. Tufano
    • 1
    Email author
  1. 1.Department of Otolaryngology – Head and Neck SurgeryJohns Hopkins School of MedicineBaltimoreUSA
  2. 2.Radiology and Radiological Science-Neuroradiology, Department of RadiologyJohns Hopkins Medical InstitutionsBaltimoreUSA

Personalised recommendations